menu
    • menu

    Company profile for Mallinckrodt Pharmaceuticals

    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our visio...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mallinckrodt PharmaceuticalsIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    College Business & Technology Park Cruiserath, Blanchardstown Dublin 15
    Telephone
    Telephone
    +353 1 6960000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mallinckrodt.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mallinckrodt/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/mnk

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 941

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    How Trump’s tariffs on imported drugs can hurt supply chains, consumers and industry

    How Trump’s tariffs on imported drugs can hurt supply chains, consumers and industry

    Ever since Donald Trump has moved into the White House for a second term, there has been turmoil across the world. One of the issues that has been of concern is ‘tariffs’. Trump is keen to reduce United States’ trade deficit through import tariffs.Since the mid-1990s, the US has been importing drugs from across the world largely tariff-free, and its drug imports have risen consistently. In 2024, the US imported US$ 213 billion worth of medicines, which was more than two and a half times the total of its drug imports ten years back.Until recently, it seemed like the administration would spare the pharmaceutical sector. But at a fundraiser dinner held for the Republican Party last week, Trump said: “We're going to be announcing very shortly a major tariff on pharmaceuticals”. The pharma tariffs, he said, would be “at a level that you haven’t really seen before”.The US is the largest consumer of pharmaceuticals globally, accounting for 45 percent of global sales. Given the nature of the global pharma industry, ‘major tariffs’ would have far-reaching impact. PharmaCompass studies the likely impact of tariffs on drug imports into the US, and whether they would serve the purpose they intend to.Cost of import tariffs, setting up domestic capacities will be borne by US consumersThe Trump administration has two key objectives behind implementing drug import tariffs. One, it wants to secure US drug supply chains by onshoring drug production. Two, it wants to create more manufacturing jobs in the US. Will tariffs be successful in achieving these objectives?Importers generally pay the tax and pass it on to the consumer. Bernstein analyst Courtney Breen estimates that in the worst-case scenario, tariffs could result in an extra US$ 53 billion in costs paid for pharmaceutical imports. According to economist Ernie Tedeschi, “costs for prescription drugs would rise by an average of around US$ 600 per year per household” in the US. Not all of that would be ‘out-of-pocket’, and families may “end up paying higher insurance premiums [and] higher co-pays”.Many drugmakers may want to avoid that cost, and shift manufacturing to the US. Though American drugmakers Eli Lilly and Johnson & Johnson have announced mega investments in the US, it’s difficult to say if other drugmakers will find it viable to set up capacities. Having said that, just this week Novartis announced a US$ 23 billion investment in the US.Overall, resources are expensive in the US. Due to heavy reliance on imports, the country does not have industrial plants needed for large-scale production. Factors like labor regulations, high cost of living, mandatory benefits etc, have made the workforce quite expensive. It’s puzzling how any drugmaker will overcome these challenges and create manufacturing jobs. Even if they do, the high costs of manufacturing will translate into costlier drugs.According to a recent report undertaken by RAND, prescription drug prices in the US are on an average 2.78 times those seen in 33 other nations. With tariffs, that gap will widen further.Drug supply chains are complex; moving capacities to US costly, time-consumingAccording to the US Food and Drug Administration (FDA), as of August 2019, only 28 percent of the facilities producing APIs for the US market were located domestically. The remaining 72 percent were overseas, with nearly half of its generics coming from India.The US is also highly dependent on drug imports for critical therapies. In 2024, the European Union supplied US$ 127 billion worth of high-value branded medicines to the US.The pharmaceutical supply chain is complex. There are a series of chemical steps involved in making any drug, with each step often being performed in different locations.The supply chain is determined by a variety of factors, such as availability of cheap labour, tax rates, supply of raw materials etc. For instance, Ireland has a very low corporate tax rate. Therefore, it has emerged as a hub for the production of APIs used in blockbuster medicines, such as Lilly’s Zepbound and Merck’s Keytruda.Moving production to the US will take five to seven years per plant. Each plant will cost US$ 2 billion or more. And it will have to go through several checks to meet America’s high regulatory standards. It is a long, arduous and unnecessary exercise, when capacities, expertise and cheaper labor is already existing in other countries.Europe also plans to onshore, leading to turbulent shift in trade dynamicsLike the US, Europe too is heavily reliant on China and India, and is working towards reducing its dependence. Over the years, Europe has moved significant resources into the US, especially in R&D. American drugmakers like Pfizer and Johnson & Johnson, on the other hand, manufacture many of their drugs in Europe and export them back to the US. Tariffs, therefore, will impact European exports in a big way. Drugmakers confronted European Commission President Ursula von der Leyen soon after Trump spoke about the pharma tariffs. These drugmakers, led by Novo Nordisk’s CEO Lars Fruergaard Jørgensen, asked for a “rapid, radical policy change” so that R&D and manufacturing doesn’t get directed towards the US.According to these drugmakers, up to 85 per cent of capital investments (about €50.6 billion, or US$ 56 billion) and up to 50 per cent of R&D expenditures (about €52.6 billion or US$ 58 billion) are potentially at risk. These figures are taken from a total of €164.8 billion (US$ 182 billion) worth of pharmaceutical investment planned in the EU during 2025 to 2029.Tariffs will test low margins of generics, may put a pause on dealmakingTariffs will have a different impact on generics. According to a Brookings report, while tariffs will “provide a strong incentive for increasing US manufacturing of brand-name drugs”, it will not be incentive enough for older, off-patent generic drugs, which “represent over 90 percent of the volume but only a small share of spending”.It will be difficult for generic drugmakers to onshore due to high capital expenditures and low and uncertain returns on investment. In fact, tariff pressure will test the wafer-thin margins of generic drugmakers in both the US and overseas. This could lead to product discontinuations or drastic cost cutting, which in turn could erode product quality.In the end, as  Arthur Wong, senior director of corporate ratings, healthcare, at S&P Global Ratings, puts it, all this chaos is going to “put a pause [on] or distract” from another key pharma function: dealmaking. The time for executing M&As was now. But we can’t expect dealmaking to return until the second half of 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1864

    https://www.pharmacompass.com/radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry

    #Phispers by PHARMACOMPASS
    17 Apr 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Mallinckrodt plc to Report Q1 2025 Earnings
    Mallinckrodt plc to Report Q1 2025 Earnings

    10 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-plc-to-report-earnings-results-for-first-quarter-2025-302424998.html

    PR NEWSWIRE
    10 Apr 2025
    Share Share
    Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
    Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger

    14 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-mallinckrodt-endo-merge-nearly-7-billion-deal-2025-03-13/

    REUTERS
    14 Mar 2025
    Share Share
    Mallinckrodt plc Reports Q4 and FY 2024 Results, 2025 Guidance
    Mallinckrodt plc Reports Q4 and FY 2024 Results, 2025 Guidance

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-plc-reports-fourth-quarter-and-fiscal-year-2024-financial-results-and-provides-2025-guidance-302400719.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share
    Mallinckrodt plc Reschedules Q4 & FY 2024 Results to March 13
    Mallinckrodt plc Reschedules Q4 & FY 2024 Results to March 13

    10 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-plc-reschedules-release-of-fourth-quarter-and-fiscal-year-2024-financial-results-to-thursday-march-13-2025-302397490.html

    PR NEWSWIRE
    10 Mar 2025
    Share Share
    CVC Completes Acquisition of Therakos from Mallinckrodt
    CVC Completes Acquisition of Therakos from Mallinckrodt

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202409570/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share
    Mallinckrodt Completes Divestiture of Therakos® Business
    Mallinckrodt Completes Divestiture of Therakos® Business

    02 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-completes-divestiture-of-therakos-business-302319183.html

    PR NEWSWIRE
    02 Dec 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Paracetamol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Paracetamol

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4203

    Submission : 1981-06-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-039 - Rev 04

    Issue Date : 2018-04-25

    Type : Chemical

    Substance Number : 49

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10905

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-11-10

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-0694

    Start Marketing Date : 2023-07-07

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Korea Johnson & Johnson Sales Co., Ltd.

    Registration Date : 2023-01-10

    Registration Number : 20050831-32-C-126-07(A)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Fentanyl

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Fentanyl

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 8074

    Submission : 1989-05-11

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2005-260 - Rev 03

    Issue Date : 2024-02-14

    Type : Chemical

    Substance Number : 1210

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10283

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2009-12-22

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-5527

    Start Marketing Date : 2001-12-21

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Nosa Chemical Co., Ltd.

    Registration Date : 2022-11-28

    Registration Number : 20221128-211-J-1415

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Fentanyl Citrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Fentanyl Citrate

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 7051

    Submission : 1987-07-02

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2009-097 - Rev 02

    Issue Date : 2024-01-30

    Type : Chemical

    Substance Number : 1103

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 229MF10161

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2017-08-17

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-1333

    Start Marketing Date : 2013-11-20

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Amphetamine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Amphetamine

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-03-17

    Pay. Date : 2013-03-11

    DMF Number : 15385

    Submission : 2001-04-18

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2020-076 - Rev 00

    Issue Date : 2021-07-26

    Type : Chemical

    Substance Number : 2752

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-4942

    Start Marketing Date : 2013-11-22

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Buprenorphine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Buprenorphine Hydrochloride

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-30

    Pay. Date : 2012-11-30

    DMF Number : 24927

    Submission : 2012-05-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-048 - Rev 00

    Issue Date : 2021-05-04

    Type : Chemical

    Substance Number : 1181

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-2910

    Start Marketing Date : 2011-12-17

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Fentanyl Citrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Fentanyl Citrate

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-12

    Pay. Date : 2012-11-27

    DMF Number : 10128

    Submission : 1993-03-15

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 218MF10580

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-06-22

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-1205

    Start Marketing Date : 2013-04-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Methylphenidate Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Methylphenidate Hydrochloride

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-08

    Pay. Date : 2012-11-27

    DMF Number : 12769

    Submission : 1997-11-25

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-140 - Rev 01

    Issue Date : 2018-02-06

    Type : Chemical

    Substance Number : 2235

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-1335

    Start Marketing Date : 2014-03-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Korea Pharma Co., Ltd.

    Registration Date : 2023-10-26

    Registration Number : 20231012-209-J-1551(A)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 3600 North Second Street, St, Louis, Missouri 63147, USA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Naloxone Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Naloxone Hydrochloride

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-11

    Pay. Date : 2012-12-07

    DMF Number : 1862

    Submission : 1972-01-25

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-294 - Rev 01

    Issue Date : 2023-08-08

    Type : Chemical

    Substance Number : 729

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-1493

    Start Marketing Date : 2020-11-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Pethidine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World Vaccine Conference
    Not Confirmed
    arrow

    Pethidine Hydrochloride

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-08-01

    Pay. Date : 2014-07-28

    DMF Number : 11345

    Submission : 1995-02-10

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 218MF10904

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-11-10

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-1585

    Start Marketing Date : 2013-11-20

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Sufentanil Citrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Sufentanil Citrate

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 12183

    Submission : 1996-10-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-095 - Rev 01

    Issue Date : 2024-05-06

    Type : Chemical

    Substance Number : 1269

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0406-0678

    Start Marketing Date : 2017-01-27

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT FOR ...

    KDMF arrow-down
    ✖

    Registrant Name : Nosa Chemical Co., Ltd.

    Registration Date : 2022-05-18

    Registration Number : 20220518-210-J-1301

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    6-beta-naltrexol Hydrochloride

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    02

    Abx And Cbx Bonded Phase Silica Gels

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    03

    Accurbron, S.r. (controlled Release ...

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    04

    Acetaminophen

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    05

    Acetaminophen Controlled-release Bea...

    Ireland
    Cophex
    Not Confirmed
    arrow

    06

    Acetaminophen Usp

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    07

    Acetoxyacetyl Chloride

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    08

    Acetoxyacetyl Chloride

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    09

    Actifed S.a. Brand Of Pseudoephedrin...

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow

    10

    Acyclovir Usp (micronized), Coded 25...

    Ireland
    MAGHREB PHARMA
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Buprenorphine

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    02

    Buprenorphine hydrochloride

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    03

    Buprenorphine hydrochloride, Process II

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    04

    Calcium stearate, (Code numbers 2246, 22...

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    05

    Codeine phosphate hemihydrate

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    06

    Desmopressin

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    07

    Dexamfetamine sulfate

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    08

    Fentanyl

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    09

    Fentanyl citrate

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow

    10

    Leuprorelin

    CEP/COS

    MAGHREB PHARMA
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    Acetaminophen

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 218MF10905

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-11-10

    Latest Date of Registration : 2009-12-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Fentanyl

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Fentanyl

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 221MF10283

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2009-12-22

    Latest Date of Registration : 2018-05-31

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Fentanyl citrate

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Fentanyl citrate

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 218MF10580

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-06-22

    Latest Date of Registration : 2006-06-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Fentanyl citrate FP

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Fentanyl citrate FP

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 229MF10161

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2017-08-17

    Latest Date of Registration : 2017-08-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Ioversol

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Ioversol

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 226MF10059

    Registrant's Address : Damastown, Mulhuddart, Dublin 15 Ireland

    Initial Date of Registration : 2014-03-06

    Latest Date of Registration : 2014-03-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Methadone hydrochloride

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Methadone hydrochloride

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 223MF10179

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2011-12-27

    Latest Date of Registration : 2012-09-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Pethidine hydrochloride

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Pethidine hydrochloride

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 218MF10904

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-11-10

    Latest Date of Registration : 2007-09-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Konpappu L

    JDMF

    MAGHREB PHARMA
    Not Confirmed
    arrow

    Konpappu L

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mallinckrodt Pharmaceuticals

    Registration Number : 218MF10631

    Registrant's Address : 385 Marshall Ave, Webster Groves, Missouri 63119, United States

    Initial Date of Registration : 2006-07-20

    Latest Date of Registration : 2016-11-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Lee Sung International Co., Ltd.

    Registration Date : 2020-07-01

    Registration Number : 20050831-32-C-126-07(C)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    02

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Korea Johnson & Johnson Sales Co., Ltd.

    Registration Date : 2009-06-26

    Registration Number : 20090626-32-C-261-14

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    03

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Korea Janssen Co., Ltd.

    Registration Date : 2005-08-31

    Registration Number : 20050831-32-C-126-07

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    04

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Korea Janssen Co., Ltd.

    Registration Date : 2005-08-31

    Registration Number : 20050831-32-C-125-06

    Manufacturer Name : SpecGx LLC@[Granule Process Ma...

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA@[Granulation Process Manuf...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    05

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : (주)애거슨바이오

    Registration Date : 2022-06-10

    Registration Number : 20050831-32-C-126-07(B)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    06

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Samyang Pharmaceutical Co., Ltd.

    Registration Date : 2011-10-21

    Registration Number : 20050831-32-C-126-07(3)

    Manufacturer Name : Spec Gx LLC

    Manufacturer Address : 8801 Capital Boulevard Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    07

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Hwail Pharmaceutical Co., Ltd.

    Registration Date : 2011-06-15

    Registration Number : 20050831-32-C-126-07(E)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    08

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Wonpung Pharmaceutical Co., Ltd.

    Registration Date : 2011-05-16

    Registration Number : 20050831-32-C-126-07(D)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    09

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Heilion Korea Co., Ltd.

    Registration Date : 2009-12-24

    Registration Number : 20091224-32-C-266-16

    Manufacturer Name : Mallinckrodt Inc.

    Manufacturer Address : Greenville Plant, Covidien, 100 Louis Latzer Drive, Greenville, Illinois 62246

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    10

    Acetaminophen

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Registrant Name : Korea Johnson & Johnson Sales Co., Ltd.

    Registration Date : 2023-01-10

    Registration Number : 20050831-32-C-126-07(A)

    Manufacturer Name : SpecGx LLC

    Manufacturer Address : 8801 Capital Boulevard, Raleigh, North Carolina 27616, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0046

    Start Marketing Date : 2013-02-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0244

    Start Marketing Date : 2013-02-11

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (0.9kg/kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0422

    Start Marketing Date : 2013-02-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0167

    Start Marketing Date : 2013-02-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0090

    Start Marketing Date : 1982-12-20

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (0.9kg/kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0081

    Start Marketing Date : 2013-02-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0161

    Start Marketing Date : 1982-12-20

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (0.9kg/kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0057

    Start Marketing Date : 2013-02-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0114

    Start Marketing Date : 2013-02-08

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (0.9kg/kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    ACETAMINOPHEN

    Ireland
    World Vaccine Conference
    Not Confirmed
    arrow

    ACETAMINOPHEN

    Ireland
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    NDC Package Code : 0406-0048

    Start Marketing Date : 2013-02-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Acetaminophen/Paracetamol

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    01

    Acetaminophen/Paracetamol

    Ireland
    Cophex
    Not Confirmed
    arrow

    Acetaminophen/Paracetamol

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amphetamine

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    02

    Amphetamine

    Ireland
    Cophex
    Not Confirmed
    arrow

    Amphetamine

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amphetamine Aspartate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    03

    Amphetamine Aspartate

    Ireland
    Cophex
    Not Confirmed
    arrow

    Amphetamine Aspartate

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amphetasul

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    04

    Amphetasul

    Ireland
    Cophex
    Not Confirmed
    arrow

    Amphetasul

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Benzphetamine

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    05

    Benzphetamine

    Ireland
    Cophex
    Not Confirmed
    arrow

    Benzphetamine

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Buprenorphine

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    06

    Buprenorphine

    Ireland
    Cophex
    Not Confirmed
    arrow

    Buprenorphine

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Buprenorphine Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    07

    Buprenorphine Hydrochloride

    Ireland
    Cophex
    Not Confirmed
    arrow

    Buprenorphine Hydrochloride

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    COCAINE HYDROCHLORIDE

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    08

    COCAINE HYDROCHLORIDE

    Ireland
    Cophex
    Not Confirmed
    arrow

    COCAINE HYDROCHLORIDE

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Codeine Phosphate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    09

    Codeine Phosphate

    Ireland
    Cophex
    Not Confirmed
    arrow

    Codeine Phosphate

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Codeine Phosphate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich his...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
    blank

    10

    Codeine Phosphate

    Ireland
    Cophex
    Not Confirmed
    arrow

    Codeine Phosphate

    Ireland
    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet pati...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million

    Details:

    Through the acquisition, CVC will leverage the Company's Therakos Uvadex (methoxsalen), a fully integrated ECP delivery system for skin manifestations of Cutaneous T-cell lymphoma.


    Lead Product(s): Methoxsalen

    Therapeutic Area: Oncology Brand Name: Uvadex

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: CVC Capital Partners

    Deal Size: $925.0 million Upfront Cash: Undisclosed

    Deal Type: Acquisition May 08, 2024

    blank

    01

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Methoxsalen

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : CVC Capital Partners

    Deal Size : $925.0 million

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million

    Details : Through the acquisition, CVC will leverage the Company's Therakos Uvadex (methoxsalen), a fully integrated ECP delivery system for skin manifestations of Cutaneous T-cell lymphoma.

    Product Name : Uvadex

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    May 08, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Gets FDA Approval for Acthar® Gel Single-Dose Pre-filled Injector

    Details:

    SelfJect (repository corticotropin) is an ACTH analogue indicated as monotherapy for infantile spasms in children under 2 and exacerbations of multiple sclerosis in adults.


    Lead Product(s): Corticotropin

    Therapeutic Area: Neurology Brand Name: Acthar

    Study Phase: Approved FDFProduct Type: Hormone

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 03, 2024

    blank

    02

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Corticotropin

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt Gets FDA Approval for Acthar® Gel Single-Dose Pre-filled Injector

    Details : SelfJect (repository corticotropin) is an ACTH analogue indicated as monotherapy for infantile spasms in children under 2 and exacerbations of multiple sclerosis in adults.

    Product Name : Acthar

    Product Type : Hormone

    Upfront Cash : Inapplicable

    January 03, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Diso...

    Details:

    Lisdexamfetamine Dimesylate Capsules are a federally controlled substance (CII) used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and other indications and currently are on the FDA's drug shortage list.


    Lead Product(s): Lisdexamfetamine Dimesylate

    Therapeutic Area: Psychiatry/Psychology Brand Name: Vyvanse-Generic

    Study Phase: Approved FDFProduct Type: Controlled Substance

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 31, 2023

    blank

    03

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lisdexamfetamine Dimesylate

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Prod...

    Details : Lisdexamfetamine Dimesylate Capsules are a federally controlled substance (CII) used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and other indications and currently are on the FDA's drug shortage list.

    Product Name : Vyvanse-Generic

    Product Type : Controlled Substance

    Upfront Cash : Inapplicable

    August 31, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder

    Details:

    INOmax® EVOLVE™ DS delivery system has been cleared by the U.S. Food and Drug Administration for the delivery of INOmax® (nitric oxide) gas, for inhalation, for the treating neonatal patients with hypoxic respiratory failure


    Lead Product(s): Nitric Oxide

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: INOmax

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 12, 2023

    blank

    04

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Nitric Oxide

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of ...

    Details : INOmax® EVOLVE™ DS delivery system has been cleared by the U.S. Food and Drug Administration for the delivery of INOmax® (nitric oxide) gas, for inhalation, for the treating neonatal patients with hypoxic respiratory failure

    Product Name : INOmax

    Product Type : Other Small Molecule

    Upfront Cash : Inapplicable

    July 12, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Silence Therapeutics to Buyback siRNA Complement Assets

    Details:

    Silence will gain rights back to 2 undisclosed complement targets. SLN501, the C3 targeting program will remain under the agreement. Silence’s proprietary mRNAi GOLD™ platform can be used to create siRNAs that precisely target and silence disease-associated genes in the liver.


    Lead Product(s): Undisclosed

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: IND EnablingProduct Type: Other Large Molecule

    Sponsor: Silence Therapeutics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement March 28, 2023

    blank

    05

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : IND Enabling

    Partner/Sponsor/Collaborator : Silence Therapeutics

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Silence Therapeutics to Buyback siRNA Complement Assets

    Details : Silence will gain rights back to 2 undisclosed complement targets. SLN501, the C3 targeting program will remain under the agreement. Silence’s proprietary mRNAi GOLD™ platform can be used to create siRNAs that precisely target and silence disease-ass...

    Product Name : Undisclosed

    Product Type : Other Large Molecule

    Upfront Cash : Undisclosed

    March 28, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gas...

    Details:

    TERLIVAZ (terlipressin) is the first and only FDA-approved product indicated to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function, an acute and life-threatening condition requiring hospitalization.


    Lead Product(s): Terlipressin Acetate

    Therapeutic Area: Nephrology Brand Name: Terlivaz

    Study Phase: Approved FDFProduct Type: Other Large Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable October 24, 2022

    blank

    06

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Terlipressin Acetate

    Therapeutic Area : Nephrology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hep...

    Details : TERLIVAZ (terlipressin) is the first and only FDA-approved product indicated to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function, an acute and life-threatening condition requiring hospitalization.

    Product Name : Terlivaz

    Product Type : Other Large Molecule

    Upfront Cash : Inapplicable

    October 24, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System

    Details:

    INOmax® (nitric oxide) gas, for inhalation, is an FDA-approved treatment that is indicated to improve oxygenation and reduce need for extracorporeal membrane oxygenation in term and near-term neonates with hypoxic respiratory failure associated.


    Lead Product(s): Nitric Oxide

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: INOmax

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 28, 2022

    blank

    07

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Nitric Oxide

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery Syst...

    Details : INOmax® (nitric oxide) gas, for inhalation, is an FDA-approved treatment that is indicated to improve oxygenation and reduce need for extracorporeal membrane oxygenation in term and near-term neonates with hypoxic respiratory failure associated.

    Product Name : INOmax

    Product Type : Other Small Molecule

    Upfront Cash : Inapplicable

    September 28, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS)

    Details:

    Terlivaz (terlipressin) is the first and only FDA-approved product indicated to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function, an acute and life-threatening condition requiring hospitalization.


    Lead Product(s): Terlipressin Acetate

    Therapeutic Area: Nephrology Brand Name: Terlivaz

    Study Phase: Approved FDFProduct Type: Other Large Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 14, 2022

    blank

    08

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Terlipressin Acetate

    Therapeutic Area : Nephrology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatm...

    Details : Terlivaz (terlipressin) is the first and only FDA-approved product indicated to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function, an acute and life-threatening condition requiring hospitalization.

    Product Name : Terlivaz

    Product Type : Other Large Molecule

    Upfront Cash : Inapplicable

    September 14, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt to Present Data on Terlipressin in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (E...

    Details:

    Teripress (Terlipressin) is an analogue of vasopressin used as a vasoactive drug in the management of hypotension which has been found to be effective when norepinephrine fails.


    Lead Product(s): Terlipressin Acetate

    Therapeutic Area: Nephrology Brand Name: Terlivaz

    Study Phase: Approved FDFProduct Type: Other Large Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 23, 2022

    blank

    09

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Terlipressin Acetate

    Therapeutic Area : Nephrology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt to Present Data on Terlipressin in Adult Patients with Hepatorenal Syndrome (HRS) at ...

    Details : Teripress (Terlipressin) is an analogue of vasopressin used as a vasoactive drug in the management of hypotension which has been found to be effective when norepinephrine fails.

    Product Name : Terlivaz

    Product Type : Other Large Molecule

    Upfront Cash : Inapplicable

    June 23, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome

    Details:

    Teripress (Terlipressin) is an investigational agent, to treat adults with hepatorenal syndrome (HRS) involving rapid reduction in kidney function, an acute and life-threatening condition.


    Lead Product(s): Terlipressin Acetate

    Therapeutic Area: Nephrology Brand Name: Terlivaz

    Study Phase: Approved FDFProduct Type: Other Large Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 13, 2022

    blank

    10

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed

    Mallinckrodt Pharmaceuticals

    Ireland
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Terlipressin Acetate

    Therapeutic Area : Nephrology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Sy...

    Details : Teripress (Terlipressin) is an investigational agent, to treat adults with hepatorenal syndrome (HRS) involving rapid reduction in kidney function, an acute and life-threatening condition.

    Product Name : Terlivaz

    Product Type : Other Large Molecule

    Upfront Cash : Inapplicable

    June 13, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-07

    Mallinckrodt Pharmaceuticals

    City : Cincinnati

    State : OH

    Country/Area : US

    Zip : 45237-1624

    District : CIN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-07

    Mallinckrodt Pharmaceuticals

    City : Cincinnati

    State : OH

    Country/Area : US

    Zip : 45237-1624

    District : CIN

    Center : CDRH

    Project Area : Postmarket Assurance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-07-25

    Mallinckrodt Pharmaceuticals

    City : Raleigh

    State : NC

    Country/Area : US

    Zip : 27616-3104

    District : ATL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-07-25

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    Mallinckrodt Pharmaceuticals

    City : Hazelwood

    State : MO

    Country/Area : US

    Zip : 63042-2513

    District : KAN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    Mallinckrodt Pharmaceuticals

    City : Hazelwood

    State : MO

    Country/Area : US

    Zip : 63042-2513

    District : KAN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    Mallinckrodt Pharmaceuticals

    City : Maryland Heights

    State : MO

    Country/Area : US

    Zip : 63043-3421

    District : KAN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    Mallinckrodt Pharmaceuticals

    City : Maryland Heights

    State : MO

    Country/Area : US

    Zip : 63043-3421

    District : KAN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-12

    Mallinckrodt Pharmaceuticals

    City : Saint Louis

    State : MO

    Country/Area : US

    Zip : 63147-3457

    District : KAN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-05-24

    Mallinckrodt Pharmaceuticals

    City : Saint Louis

    State : MO

    Country/Area : US

    Zip : 63147-3457

    District : KAN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2013-05-24

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    World Vaccine Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    World Vaccine Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-03-27

    Mallinckrodt Pharmaceuticals

    City : Maryland Heights

    State : MO

    Country/Area : US

    Zip : 63043-3421

    District : KAN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2013-03-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Mallinckrodt Plc and get a quotation

    Mallinckrodt Plc is a supplier offers 162 products (APIs, Excipients or Intermediates).

    Find a price of Paracetamol bulk with DMF, CEP, JDMF offered by Mallinckrodt Plc

    Find a price of Fentanyl bulk with CEP, JDMF offered by Mallinckrodt Plc

    Find a price of Fentanyl Citrate bulk with CEP, JDMF offered by Mallinckrodt Plc

    Find a price of Amphetamine bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Buprenorphine bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Codeine Phosphate bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Fentanyl Citrate bulk with DMF, JDMF offered by Mallinckrodt Plc

    Find a price of Ioversol bulk with DMF, JDMF offered by Mallinckrodt Plc

    Find a price of Methylphenidate Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Naltrexone Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Pethidine Hydrochloride bulk with DMF, JDMF offered by Mallinckrodt Plc

    Find a price of Sufentanil Citrate bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Calcium Stearate API bulk with CEP offered by Mallinckrodt Plc

    Find a price of Methadone Hydrochloride bulk with JDMF offered by Mallinckrodt Plc

    Find a price of Oxycodone Hydrochloride bulk with CEP offered by Mallinckrodt Plc

    Find a price of Amphetamine bulk with DMF offered by Mallinckrodt Plc

    Find a price of Amphetamine Aspartate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Chlorpheniramine bulk with DMF offered by Mallinckrodt Plc

    Find a price of Cocaine Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Codeine Sulfate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Corticotropin bulk with DMF offered by Mallinckrodt Plc

    Find a price of Desmopressin Acetate bulk offered by Mallinckrodt Plc

    Find a price of Dexchloropheniramine Maleate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Dexmethylphenidate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Dihydrocodeine Tartrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Diphenoxylate Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Fentanyl bulk with DMF offered by Mallinckrodt Plc

    Find a price of Gallium Chloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Hydromorphone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Ibuprofen bulk with DMF offered by Mallinckrodt Plc

    Find a price of Indium Trichloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Iotalamic Acid bulk with DMF offered by Mallinckrodt Plc

    Find a price of Ioversol bulk with DMF offered by Mallinckrodt Plc

    Find a price of Leuprolide Acetate bulk offered by Mallinckrodt Plc

    Find a price of Levorphanol Tartrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Lisdexamfetamine Dimesylate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Magnesium bulk with CEP offered by Mallinckrodt Plc

    Find a price of Methadone bulk with DMF offered by Mallinckrodt Plc

    Find a price of Methadone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Methylphenidate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Morphine Sulfate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Nalbuphine Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Nalmefene Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Naltrexone bulk with DMF offered by Mallinckrodt Plc

    Find a price of Naltrexone Methobromide bulk with DMF offered by Mallinckrodt Plc

    Find a price of Noscapine bulk with DMF offered by Mallinckrodt Plc

    Find a price of Octreoscan bulk with DMF offered by Mallinckrodt Plc

    Find a price of Opium bulk with DMF offered by Mallinckrodt Plc

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Oxymorphone bulk with DMF offered by Mallinckrodt Plc

    Find a price of Oxymorphone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Paracetamol bulk with DMF offered by Mallinckrodt Plc

    Find a price of Pentetic Acid bulk with DMF offered by Mallinckrodt Plc

    Find a price of Sodium Molybdate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Sufentanil Citrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Thallium Chloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of DCI-90 bulk with DMF offered by Mallinckrodt Plc

    Find a price of Konpappu L bulk with JDMF offered by Mallinckrodt Plc

    Find a price of Acetoxyacetyl Chloride bulk offered by Mallinckrodt Plc

    Find a price of Aciclovir bulk offered by Mallinckrodt Plc

    Find a price of Amphetamine bulk offered by Mallinckrodt Plc

    Find a price of Benzphetamine bulk offered by Mallinckrodt Plc

    Find a price of Butalbital bulk offered by Mallinckrodt Plc

    Find a price of Calcitonin bulk offered by Mallinckrodt Plc

    Find a price of Chlorzoxazone bulk offered by Mallinckrodt Plc

    Find a price of Codeine Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Dextropropoxyphene bulk offered by Mallinckrodt Plc

    Find a price of Disodium Hydrogen Phosphate bulk offered by Mallinckrodt Plc

    Find a price of Docusate Potassium bulk offered by Mallinckrodt Plc

    Find a price of Docusate Sodium bulk offered by Mallinckrodt Plc

    Find a price of Doxylamine Succinate bulk offered by Mallinckrodt Plc

    Find a price of Exenatide bulk offered by Mallinckrodt Plc

    Find a price of Exenatide Synthetic bulk offered by Mallinckrodt Plc

    Find a price of Fentanyl Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Ferrous Fumarate bulk offered by Mallinckrodt Plc

    Find a price of Gadoversetamide bulk offered by Mallinckrodt Plc

    Find a price of Gallium Chloride bulk offered by Mallinckrodt Plc

    Find a price of Hydrocodone Bitartrate bulk offered by Mallinckrodt Plc

    Find a price of Hydromorphone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Ibuprofen bulk offered by Mallinckrodt Plc

    Find a price of Indium bulk offered by Mallinckrodt Plc

    Find a price of Iotalamic Acid bulk offered by Mallinckrodt Plc

    Find a price of Isosorbide Dinitrate bulk offered by Mallinckrodt Plc

    Find a price of Lenperone bulk offered by Mallinckrodt Plc

    Find a price of Levorphanol Tartrate bulk offered by Mallinckrodt Plc

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Mallinckrodt Plc

    Find a price of Methadone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Morphine Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Nalbuphine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Naltrexone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Naltrexone Methobromide bulk offered by Mallinckrodt Plc

    Find a price of Natriuretic Peptide, Brain bulk offered by Mallinckrodt Plc

    Find a price of Noscapine bulk offered by Mallinckrodt Plc

    Find a price of Octreoscan bulk offered by Mallinckrodt Plc

    Find a price of Oxycodone Terephthalate bulk offered by Mallinckrodt Plc

    Find a price of Oxymorphone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Paracetamol bulk offered by Mallinckrodt Plc

    Find a price of Pemoline bulk offered by Mallinckrodt Plc

    Find a price of Pentazocine bulk offered by Mallinckrodt Plc

    Find a price of Perflutren bulk offered by Mallinckrodt Plc

    Find a price of Pethidine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Potassium Chloride bulk offered by Mallinckrodt Plc

    Find a price of Potassium Iodide bulk offered by Mallinckrodt Plc

    Find a price of Potassium Nitrate bulk offered by Mallinckrodt Plc

    Find a price of Pramlintide bulk offered by Mallinckrodt Plc

    Find a price of Propoxyphene Napsylate bulk offered by Mallinckrodt Plc

    Find a price of Pseudoephedrine bulk offered by Mallinckrodt Plc

    Find a price of Pseudoephedrine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Reserpine bulk offered by Mallinckrodt Plc

    Find a price of Selenium Methionine bulk offered by Mallinckrodt Plc

    Find a price of Silicon Dioxide API bulk offered by Mallinckrodt Plc

    Find a price of Silver Sulfadiazine bulk offered by Mallinckrodt Plc

    Find a price of Sodium Bitartrate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Dihydrogen Phosphate Monohydrate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Fluoride bulk offered by Mallinckrodt Plc

    Find a price of Sodium Iodide bulk offered by Mallinckrodt Plc

    Find a price of Sodium Perrhenate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Zomepirac bulk offered by Mallinckrodt Plc

    Find a price of Strontium Nitrate bulk offered by Mallinckrodt Plc

    Find a price of Tetrahydrocannabinol bulk offered by Mallinckrodt Plc

    Find a price of Thallium Chloride bulk offered by Mallinckrodt Plc

    Find a price of Theophylline bulk offered by Mallinckrodt Plc

    Find a price of Tolmetin Sodium bulk offered by Mallinckrodt Plc

    Find a price of Ziconotide bulk offered by Mallinckrodt Plc

    Find a price of HEXABRIX X-RAY CONTRAST MEDIA bulk offered by Mallinckrodt Plc

    Find a price of PROSAPTIDE bulk offered by Mallinckrodt Plc

    Find a price of INVESTIGATIONAL DRUGS bulk offered by Mallinckrodt Plc

    Find a price of FACILS & PERSONNEL FOR THE RAD PHARM INC CYCLOTRIN ON MAHLER RD. CA. bulk offered by Mallinckrodt Plc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN PETTEN, HOLLAND FACILITY. bulk offered by Mallinckrodt Plc

    Find a price of CYCLOTRON FACILITY-MARYLAND HEIGHTS, MO. bulk offered by Mallinckrodt Plc

    Find a price of MANUFACTURING FACILITY AT RALEIGH, NORTH CAROLINA bulk offered by Mallinckrodt Plc

    Find a price of FACILITIES, PROCEDURES AND PERSONNEL bulk offered by Mallinckrodt Plc

    Find a price of X-RAY CONTRAST MEDIA bulk offered by Mallinckrodt Plc

    Find a price of PROSAPTIDE TX 14(A), CODE 8200 bulk offered by Mallinckrodt Plc

    Find a price of BIOLOGICAL INDICATOR PROGRAM APPLIED MARYLAND HEIGHTS, MO PLANT SITE bulk offered by Mallinckrodt Plc

    Find a price of CODACET-60 (TM) bulk offered by Mallinckrodt Plc

    Find a price of SOD. IODIDE I-123 RADIOCHEM. SOL.-BURLINGAME,CA-(DMF FORMERLY RADPHARM bulk offered by Mallinckrodt Plc

    Find a price of FACILITIES-PERSONNEL-GEN. OPERATING PROCEDURES RALEIGH NC CHEM. PLANT bulk offered by Mallinckrodt Plc

    Find a price of MANUFACTURING & CONTROLS FOR LEVO ALPHA METHADYL ACETATE HYDROCHLORIDE bulk offered by Mallinckrodt Plc

    Find a price of GASTROMARK (FERUMOXSIL) BOWEL MARKER bulk offered by Mallinckrodt Plc

    Find a price of DEXTROCET-N2000 bulk offered by Mallinckrodt Plc

    Find a price of CT50034 bulk offered by Mallinckrodt Plc

    Find a price of MERCURY 195M/GOLD 195M GENERATORS-FACILS,METHDS,CONTRL FOR PREPARATION bulk offered by Mallinckrodt Plc

    Find a price of COMPAP (TM) bulk offered by Mallinckrodt Plc

    Find a price of PRODUCTION OF TALLOUS T1-201 CHL AT THE BURLINGAME, CA bulk offered by Mallinckrodt Plc

    Find a price of FACILITIES, PERSONNEL,AND G.O.P. FOR THE ST. LOUIS, MISSOURI PLANT bulk offered by Mallinckrodt Plc

    Find a price of MOLYDENUM 99:TECHNETIUM-99M bulk offered by Mallinckrodt Plc

    Find a price of Atropine Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Buprenorphine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Chlorpheniramine Maleate bulk offered by Mallinckrodt Plc

    Find a price of Codeine Phosphate bulk offered by Mallinckrodt Plc

    Find a price of Dihydrocodeine Tartrate bulk offered by Mallinckrodt Plc

    Find a price of Fentanyl Citrate bulk offered by Mallinckrodt Plc

    Find a price of Methylphenidate Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Naloxone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Nitric Oxide bulk offered by Mallinckrodt Plc

    Find a price of Recombinant Human Growth Hormone bulk offered by Mallinckrodt Plc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search